Background Cancer survivors—people living with and beyond cancer—are a growing
population with different health needs depending on prognosis and time since diagnosis …

Introduction Comparable indicators on complete cancer prevalence are increasingly needed
in Europe to support survivorship care planning. Direct measures can be biased by limited …

Introduction Europe is an important focus for compiling accurate and up-to-date world
cancer statistics owing to its large share of the world's total cancer burden. This article …

Background Complete cancer prevalence data in Europe have never been updated after the
first estimates provided by the EUROPREVAL project and referred to the year 1993. This …

Introduction Europe contains 9% of the world population but has a 25% share of the global
cancer burden. Up-to-date cancer statistics in Europe are key to cancer planning. Cancer …

Background Population-based cancer survival estimates provide valuable insights into the
effectiveness of cancer services and can reflect the prospects of cure. As part of the second …

Background Cancers are the leading cause of death in England. We aimed to estimate
trends in mortality from leading cancers from 2002 to 2019 for the 314 districts in England …

Background Cancer survival is a key measure of the effectiveness of health-care systems.
EUROCARE—the largest cooperative study of population-based cancer survival in Europe …

Background Estimates of cancer prevalence are widely based on limited duration, often
including patients living after a cancer diagnosis made in the previous 5 years and less …

Background The number and projections of cancer survivors are necessary to meet the
healthcare needs of patients, while data on cure prevalence, that is, the percentage of …